These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7583599)

  • 21. Propensity scores.
    Cummings P
    Arch Pediatr Adolesc Med; 2008 Aug; 162(8):734-7. PubMed ID: 18678805
    [No Abstract]   [Full Text] [Related]  

  • 22. [This is the truth].
    Holt J; Økland O; Meberg A; Danielsen K; Grønn M; Silberg IE
    Tidsskr Nor Laegeforen; 2006 Oct; 126(20):2690; author reply 2690-1. PubMed ID: 17057780
    [No Abstract]   [Full Text] [Related]  

  • 23. Pumactant and poractant alfa in respiratory distress syndrome.
    Wardhaugh AD; Matthes JW
    Lancet; 2000 Aug; 356(9231):765-6. PubMed ID: 11085711
    [No Abstract]   [Full Text] [Related]  

  • 24. [Nursing aspects in the treatment of respiratory distress syndrome].
    Meyer A; Günther S
    Kinderkrankenschwester; 1995 Mar; 14(3):115-6. PubMed ID: 7703162
    [No Abstract]   [Full Text] [Related]  

  • 25. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Natural surfactants: Are there really any differences?].
    Noguera Moya A
    An Esp Pediatr; 2002 Dec; 57(6):583. PubMed ID: 12466086
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanisms to explain surfactant responses.
    Jobe AH
    Biol Neonate; 2006; 89(4):298-302. PubMed ID: 16770069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surfactant therapy in the USA: trials and current routines.
    Soll RF
    Biol Neonate; 1997; 71 Suppl 1():1-7. PubMed ID: 9209741
    [No Abstract]   [Full Text] [Related]  

  • 29. [Natural surfactants: Yes, there really are differences].
    Navas Serrano VM; Cuevas García MA; Vila Alvarez JA; Martínez Fernández V; Morcillo Sopena F; Valls Soler A
    An Esp Pediatr; 2002 Dec; 57(6):584. PubMed ID: 12466087
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical trials of natural surfactant extract in respiratory distress syndrome.
    Mercier CE; Soll RF
    Clin Perinatol; 1993 Dec; 20(4):711-35. PubMed ID: 8131364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent clinical trials of surfactant treatment for neonates.
    Halliday HL
    Biol Neonate; 2006; 89(4):323-9. PubMed ID: 16770072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled nitric oxide treatment for preterm infants with hypoxic respiratory failure.
    Smyth RL
    Thorax; 2000 Aug; 55 Suppl 1(Suppl 1):S51-5. PubMed ID: 10943640
    [No Abstract]   [Full Text] [Related]  

  • 33. Natural vs synthetic surfactants in neonatal respiratory distress syndrome.
    Halliday HL
    Drugs; 1996 Feb; 51(2):226-37. PubMed ID: 8808165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome.
    Walti H; Monset-Couchard M
    Drug Saf; 1998 May; 18(5):321-37. PubMed ID: 9589844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The DART study of low-dose dexamethasone therapy.
    Rademaker KJ; Groenendaal F; van Bel F; de Vries LS; Uiterwaal CS
    Pediatrics; 2007 Sep; 120(3):689-90; author reply 690-1. PubMed ID: 17766548
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhaled nitric oxide in premature neonates.
    Modi N; Doré C
    Lancet; 1999 Dec 18-25; 354(9196):2162; author reply 2163. PubMed ID: 10609838
    [No Abstract]   [Full Text] [Related]  

  • 37. Surfactant therapy and nasal CPAP for newborns with RDS.
    Chugh K
    Indian Pediatr; 1995 Apr; 32(4):513-4. PubMed ID: 8635825
    [No Abstract]   [Full Text] [Related]  

  • 38. On "A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants" (Am J Perinatol 2004;21:109-120).
    Bancalari E
    Am J Perinatol; 2004 Jul; 21(5):307-9. PubMed ID: 15232767
    [No Abstract]   [Full Text] [Related]  

  • 39. Does surfactant therapy prolong dying? Age at in-hospital death of extremely premature babies.
    Coulter DM; Jung AL
    J Perinatol; 1996; 16(3 Pt 1):166-70; quiz 171-2. PubMed ID: 8817423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Two Different Exogenous Surfactant Preparations on Serial Peripheral Perfusion Index and Tissue Carbon Monoxide Measurements in Preterm Infants with Severe Respiratory Distress Syndrome.
    Jeng MJ
    Pediatr Neonatol; 2015 Aug; 56(4):211-2. PubMed ID: 25892643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.